> Genomic Health has set the terms of its IPO, with plans to offer 5 million shares at $12 to $14 per share. Story
> The National Institutes of Health has provided a $10.1 million grant to Progenics to help fund the continued development of its HIV drug. Story
> India's Ranbaxy plans to raise $100 million to fund new foreign acquisitions. Article
> Germany's BioVisioN has inked a deal to collaborate with Abbott on developing biomarkers for lung cancer. Story
> Eli Lilly is teaming with Immunetrics to identify biomarkers and design more efficient clinical trials. Report
> King Pharmaceuticals of Bristol, Tennessee, and Inyx have entered into a co-marketing alliance for King's Intal and Tilade respiratory therapies. Story
And Finally… The AIDS epidemic in Africa has decimated the ranks of farmers, cutting the amount of cultivated land by as much as 70 percent in some areas of the continent. Article